J Korean Surg Soc.  2012 Jan;82(1):45-49. 10.4174/jkss.2012.82.1.45.

Inflammatory myofibroblastic tumor in colon

• Kim EY
• Lee IK
• Lee YS
• Yang N
• Chung DJ
• Yim KI
• Kim JI
• Oh ST

• KMID: 1437757
• DOI: http://doi.org/10.4174/jkss.2012.82.1.45

Abstract

Inflammatory myofibroblastic tumor (IMT) is an uncommon mesenchymal solid tumor commonly documented in children and young adults. Here, we report a case of IMT in colon confirmed pathologically after laparoscopic anterior resection. A 35-year-old man presented with anal bleeding after defecation for 2 weeks. Colonoscopy demonstrated a mass with shallow ulceration in the central area and irregular margin accompanied by intact mucosa in the descending colon. Computer tomography showed a well-demarcated and homogenous solitary mass in the descending colon. We performed laparoscopic anterior resection. This case was diagnosed as IMT after microscopic examination. The tumor was composed of a proliferation of spindle-shaped cells arranged in the hyaline material with chronic inflammatory cells, composed mainly of plasma cells and lymphocytes. Immunohistochemically, tumor cells were positive for smooth muscle actin, and vimentin, and negative for desmin, CD117 (c-kit), anaplastic lymphoma kinase-1.

Keyword

Inflammatory myofibroblastic tumor; Colon

MeSH Terms

Actins
Adult
Child
Colon
Colon, Descending
Colonoscopy
Defecation
Desmin
Hemorrhage
Humans
Hyalin
Lymphocytes
Lymphoma
Mucous Membrane
Muscle, Smooth
Myofibroblasts
Plasma Cells
Ulcer
Vimentin
Young Adult
Actins
Desmin
Vimentin

Figure

• 

  Fig. 1 Endoscopic examination reveals a 4 cm sized irregularly margined mass with intact mucosa (margin) and shallow ulcer (central) in descending colon.

• 

  Fig. 2 Trans-axial view (A) and coronal view (B) show a 4.0 cm sized homogeneous enhancing intra-luminal mass (arrow) in descending colon.

• 

  Fig. 3 Gross examination reveals a 3.9 × 3.8 cm sized, fungating, white to yellow colored and hard mass in descending colon. Mass involves muscularis propria.

• 

  Fig. 4 Tumor is composed of cytologically bland spinle cells arranged in hyaline stroma with scattered inflammatory cells. Inflammatory cells are composed of lymphocytes, histiocytes and plasma cells (A, H&E, ×40; B, H&E, ×400).

• 

  Fig. 5 Tumor cells stain strongly for vimentin and variably with myoid markers including smooth muscle actin, muscle-specific actin and desmin (A, vimentin, ×200; B, actin, ×200).

Reference

1. Tanaka A, Hirabayashi K, Sadahiro S, Maeda Y, Suzuki T, Ogoshi K. Inflammatory myofibroblastic tumor of the ascending colon in adults manifested by positive fecal occult blood test. Gastrointest Endosc. 2010. 71:214–216.

2. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007. 31:509–520.

3. Saleem MI, Ben-Hamida MA, Barrett AM, Bunn SK, Huntley L, Wood KM, et al. Lower abdominal inflammatory myofibroblastic tumor -an unusual presentation-a case report and brief literature review. Eur J Pediatr. 2007. 166:679–683.

4. Salameh M, Sultan I, Barbar M, Al Hussaini M, Jameel A, Ghandour K, et al. Inflammatory myofibroblastic tumor causing unexplained anemia in a toddler: a case report. J Med Case Reports. 2011. 5:69.

5. Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R, et al. Inflammatory myofibroblastic tumors. J Surg Oncol. 2006. 94:385–391.

6. Karnak I, Senocak ME, Ciftci AO, Cağlar M, Bingöl-Koloğlu M, Tanyel FC, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg. 2001. 36:908–912.

7. Coffin CM, Fletcher JA. Fletcher CD, Unni KK, Mertens F, editors. Inflammatory myofibroblastic tumour. World Health Organization classification of tumours Pathology and genetics of tumours of soft tissue and bone. 2002. Lyon: IARC Press;91–93.

8. Greenson JK. Gastrointestinal stromal tumors and other mesenchymal lesions of the gut. Mod Pathol. 2003. 16:366–375.

9. Chun YS, Wang L, Nascimento AG, Moir CR, Rodeberg DA. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis. Pediatr Blood Cancer. 2005. 45:796–801.

10. Jiang YH, Cheng B, Ge MH, Cheng Y, Zhang G. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours. J Int Med Res. 2009. 37:867–877.